<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Histologic components of the TNM classification system have been repeatedly revised since the fifth edition (TNM5) </plain></SENT>
<SENT sid="1" pm="."><plain>TNM classification revisions provide different criteria for categorizing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> nodules without residual lymph node structure (ND) </plain></SENT>
<SENT sid="2" pm="."><plain>However, there are few systematic evaluations regarding the effectiveness of these revisions </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: A multicenter pathologic review for ND in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) was performed </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> staging defined by TNM5, sixth edition (TNM6), and seventh edition (TNM7) were compared on the basis of Akaike information criterion (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>) and Harrell's concordance index (c-index) </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, TNM7's prognostic value was compared between the original ND and modified criteria, which considered <z:hpo ids='HP_0000001'>all</z:hpo> regional NDs as lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (LNM) irrespective of the original structure </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In 1,716 treated patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (1994 to 1998), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stages (I/II/III) exhibited better prognoses in TNM7 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>, 3055.1; c-index, 0.7215) than in TNM6 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>, 3063.7; c-index, 0.7149), but not better than in TNM5 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>, 3051.6; c-index, 0.7240) </plain></SENT>
<SENT sid="7" pm="."><plain>Comparing the original TNM7 and modified criteria, 4.2% of patients were classified in different N stages (N0/N1/N2a/N2b); both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e> and the c-index were superior in the modified criteria (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>, 3029.40; c-index, 0.7271) compared with the original criteria (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIC</z:e>, 3040.58; c-index, 0.7230) </plain></SENT>
<SENT sid="8" pm="."><plain>Modified criteria were also associated with improved prognostic power of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stages (I/IIA/IIB/IIC/IIIA/IIIB/IIIC) </plain></SENT>
<SENT sid="9" pm="."><plain>These results were similar in another cohort of 2,242 treated patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (1999 to 2003) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The prognostic value of TNM7 is better than that of TNM6; however, improvement over TNM5 is insignificant </plain></SENT>
<SENT sid="11" pm="."><plain>By considering <z:hpo ids='HP_0000001'>all</z:hpo> regional NDs as LNM irrespective of their <z:mp ids='MP_0000002'>morphology</z:mp>, TNM classification can be simplified and its prognostic value improved </plain></SENT>
</text></document>